Related references
Note: Only part of the references are listed.Elevated levels of ferritin in the cerebrospinal fluid of amyotrophic lateral sclerosis patients
Y. Zheng et al.
ACTA NEUROLOGICA SCANDINAVICA (2017)
Diagnostic and prognostic significance of neurofilament light chain NF-L, but not progranulin and S100B, in the course of amyotrophic lateral sclerosis: Data from the German MND-net
Petra Steinacker et al.
AMYOTROPHIC LATERAL SCLEROSIS AND FRONTOTEMPORAL DEGENERATION (2017)
Neurofilament Levels as Biomarkers in Asymptomatic and Symptomatic Familial Amyotrophic Lateral Sclerosis
Patrick Weydt et al.
ANNALS OF NEUROLOGY (2016)
Assessment of a multiple biomarker panel for diagnosis of amyotrophic lateral sclerosis
Xueping Chen et al.
BMC NEUROLOGY (2016)
ALS: Recent Developments from Genetics Studies
Martine Therrien et al.
CURRENT NEUROLOGY AND NEUROSCIENCE REPORTS (2016)
Phosphorylated neurofilament heavy chain levels in paired plasma and CSF of amyotrophic lateral sclerosis
Siyuan Li et al.
JOURNAL OF THE NEUROLOGICAL SCIENCES (2016)
Tracing the voyage of SELDI-TOF MS in cancer biomarker discovery and its current depreciation trend - need for resurrection?
Manikandan Muthu et al.
TRAC-TRENDS IN ANALYTICAL CHEMISTRY (2016)
Proteomic analysis of cerebrospinal fluid in amyotrophic lateral sclerosis
Yan Chen et al.
EXPERIMENTAL AND THERAPEUTIC MEDICINE (2016)
Modified serpinA1 as risk marker for Parkinson's disease dementia: Analysis of baseline data
Steffen Halbgebauer et al.
SCIENTIFIC REPORTS (2016)
Multicenter validation of CSF neurofilaments as diagnostic biomarkers for ALS
Patrick Oeckl et al.
AMYOTROPHIC LATERAL SCLEROSIS AND FRONTOTEMPORAL DEGENERATION (2016)
Association of Cerebrospinal Fluid Neurofilament Light Concentration With Alzheimer Disease Progression
Henrik Zetterberg et al.
JAMA NEUROLOGY (2016)
Neurofilament light chain: a biomarker for genetic frontotemporal dementia
Lieke H. Meeter et al.
ANNALS OF CLINICAL AND TRANSLATIONAL NEUROLOGY (2016)
VGF Protein and Its C-Terminal Derived Peptides in Amyotrophic Lateral Sclerosis: Human and Animal Model Studies
Carla Brancia et al.
PLOS ONE (2016)
Label-Free LC-MS/MS Proteomic Analysis of Cerebrospinal Fluid Identifies Protein/Pathway Alterations and Candidate Biomarkers for Amyotrophic Lateral Sclerosis
Mahlon A. Collins et al.
JOURNAL OF PROTEOME RESEARCH (2015)
Chitotriosidase and lysosomal enzymes as potential biomarkers of disease progression in amyotrophic lateral sclerosis: A survey clinic-based study
Veronica Pagliardini et al.
JOURNAL OF THE NEUROLOGICAL SCIENCES (2015)
Depletion of highly abundant proteins from human cerebrospinal fluid: a cautionary note
Ramona Guenther et al.
MOLECULAR NEURODEGENERATION (2015)
Identification of novel CSF biomarkers for neurodegeneration and their validation by a high-throughput multiplexed targeted proteomic assay
Wendy E. Heywood et al.
MOLECULAR NEURODEGENERATION (2015)
Neurofilament light chain A prognostic biomarker in amyotrophic lateral sclerosis
Ching-Hua Lu et al.
NEUROLOGY (2015)
An Integrated Workflow for Multiplex CSF Proteomics and Peptidomics-Identification of Candidate Cerebrospinal Fluid Biomarkers of Alzheimer's Disease
Mikko Holtta et al.
JOURNAL OF PROTEOME RESEARCH (2015)
CSF neurofilament light chain reflects corticospinal tract degeneration in ALS
Ricarda A. L. Menke et al.
ANNALS OF CLINICAL AND TRANSLATIONAL NEUROLOGY (2015)
Increased Circulating Th17 Cell Populations and Elevated CSF Osteopontin and IL-17 Concentrations in Patients with Guillain-Barr, Syndrome
Rong kun Han et al.
JOURNAL OF CLINICAL IMMUNOLOGY (2014)
State of play in amyotrophic lateral sclerosis genetics
Alan E. Renton et al.
NATURE NEUROSCIENCE (2014)
Cystatin C protects neuronal cells against mutant copper-zinc superoxide dismutase-mediated toxicity
S. Watanabe et al.
CELL DEATH & DISEASE (2014)
Multicentre quality control evaluation of different biomarker candidates for amyotrophic lateral sclerosis
Stefan Lehnert et al.
AMYOTROPHIC LATERAL SCLEROSIS AND FRONTOTEMPORAL DEGENERATION (2014)
Modulation of Chitotriosidase During Macrophage Differentiation
Michelino Di Rosa et al.
CELL BIOCHEMISTRY AND BIOPHYSICS (2013)
Phosphorylated neurofilament heavy subunit (pNF-H) in peripheral blood and CSF as a potential prognostic biomarker in amyotrophic lateral sclerosis
Kevin B. Boylan et al.
JOURNAL OF NEUROLOGY NEUROSURGERY AND PSYCHIATRY (2013)
CSF inflammation and axonal damage are increased and correlate in progressive multiple sclerosis
Jeppe Romme Christensen et al.
MULTIPLE SCLEROSIS JOURNAL (2013)
A comparative study of CSF neurofilament light and heavy chain protein in MS
Jens Kuhle et al.
MULTIPLE SCLEROSIS JOURNAL (2013)
Increased Neurofilament Light Chain Blood Levels in Neurodegenerative Neurological Diseases
Johanna Gaiottino et al.
PLOS ONE (2013)
pNfH is a promising biomarker for ALS
Jeban Ganesalingam et al.
AMYOTROPHIC LATERAL SCLEROSIS AND FRONTOTEMPORAL DEGENERATION (2013)
Altered cerebrospinal fluid index of prealbumin, fibrinogen, and haptoglobin in patients with Guillain-Barre syndrome and chronic inflammatory demyelinating polyneuropathy
H. -L. Zhang et al.
ACTA NEUROLOGICA SCANDINAVICA (2012)
Roadmap and standard operating procedures for biobanking and discovery of neurochemical markers in ALS
Markus Otto et al.
AMYOTROPHIC LATERAL SCLEROSIS (2012)
Elevated cerebrospinal fluid neurofilament light levels in patients with amyotrophic lateral sclerosis: a possible marker of disease severity and progression
R. Tortelli et al.
EUROPEAN JOURNAL OF NEUROLOGY (2012)
The influence of ageing in the cerebrospinal fluid concentrations of proteins that are derived from the choroid plexus, brain, and plasma
Carl P. C. Chen et al.
EXPERIMENTAL GERONTOLOGY (2012)
Vgf is a novel biomarker associated with muscle weakness in amyotrophic lateral sclerosis (ALS), with a potential role in disease pathogenesis
Zhong Zhao et al.
International Journal of Medical Sciences (2012)
Neurofilaments at a glance
Aidong Yuan et al.
JOURNAL OF CELL SCIENCE (2012)
Neuroproteomics: an insight into ALS
D. M. F. Mendonca et al.
NEUROLOGICAL RESEARCH (2012)
Chitinase enzyme activity in CSF is a powerful biomarker of Alzheimer disease
M. Watabe-Rudolph et al.
NEUROLOGY (2012)
Monitoring CSF Proteome Alterations in Amyotrophic Lateral Sclerosis: Obstacles and Perspectives in Translating a Novel Marker Panel to the Clinic
Nils von Neuhoff et al.
PLOS ONE (2012)
Differential Sialylation of Serpin A1 in the Early Diagnosis of Parkinson's Disease Dementia
Sarah Jesse et al.
PLOS ONE (2012)
Serum and Cerebrospinal Fluid Levels of Transthyretin in Lewy Body Disorders with and without Dementia
Walter Maetzler et al.
PLOS ONE (2012)
Riluzole for amyotrophic lateral sclerosis (ALS)/motor neuron disease (MND)
Robert G. Miller et al.
COCHRANE DATABASE OF SYSTEMATIC REVIEWS (2012)
Combination of neurofilament heavy chain and complement C3 as CSF biomarkers for ALS
Jeban Ganesalingam et al.
JOURNAL OF NEUROCHEMISTRY (2011)
On the Development of Plasma Protein Biomarkers
Silvia Surinova et al.
JOURNAL OF PROTEOME RESEARCH (2011)
Anatomy and physiology of cerebrospinal fluid
L. Sakka et al.
EUROPEAN ANNALS OF OTORHINOLARYNGOLOGY-HEAD AND NECK DISEASES (2011)
Amyotrophic lateral sclerosis: one or multiple causes?
Aline Furtado Bastos et al.
NEUROLOGY INTERNATIONAL (2011)
High-abundance protein depletion: Comparison of methods for human plasma biomarker discovery
Veronika Polaskova et al.
ELECTROPHORESIS (2010)
Effects of alpha 1-antitrypsin on endotoxin-induced lung inflammation in vivo
Devipriya Subramaniyam et al.
INFLAMMATION RESEARCH (2010)
Incidence of amyotrophic lateral sclerosis in Europe
Giancarlo Logroscino et al.
JOURNAL OF NEUROLOGY NEUROSURGERY AND PSYCHIATRY (2010)
DISCOVERY AND VERIFICATION OF AMYOTROPHIC LATERAL SCLEROSIS BIOMARKERS BY PROTEOMICS
Henrik Ryberg et al.
MUSCLE & NERVE (2010)
Proteome analysis reveals candidate markers of disease progression in amyotrophic lateral sclerosis (ALS)
Johannes Brettschneider et al.
NEUROSCIENCE LETTERS (2010)
Cystatin C: A Candidate Biomarker for Amyotrophic Lateral Sclerosis
Meghan E. Wilson et al.
PLOS ONE (2010)
Analyses of transthyretin concentration in the cerebrospinal fluid of patients with Guillain-Barre syndrome and other neurological disorders
Han-Lin Chiang et al.
CLINICA CHIMICA ACTA (2009)
Plasma chitotriosidase activity in multiple sclerosis
M. Comabella et al.
CLINICAL IMMUNOLOGY (2009)
Non-cell autonomous toxicity in neurodegenerative disorders: ALS and beyond
Hristelina Ilieva et al.
JOURNAL OF CELL BIOLOGY (2009)
Immunoreactivity of the phosphorylated axonal neurofilament H subunit (pNF-H) in blood of ALS model rodents and ALS patients: evaluation of blood pNF-H as a potential ALS biomarker
Kevin Boylan et al.
JOURNAL OF NEUROCHEMISTRY (2009)
CSF neurofilament protein analysis in the differential diagnosis of ALS
Thierry S. Reijn et al.
JOURNAL OF NEUROLOGY (2009)
Decreased Cystatin C Immunoreactivity in Spinal Motor Neurons and Astrocytes in Amyotrophic Lateral Sclerosis
Fumiaki Mori et al.
JOURNAL OF NEUROPATHOLOGY AND EXPERIMENTAL NEUROLOGY (2009)
Cystatin C in cerebrospinal fluid as a biomarker of ALS
Sachiko Tsuji-Akimoto et al.
NEUROSCIENCE LETTERS (2009)
Biomarkers for lysosomal storage disorders: identification and application as exemplified by chitotriosidase in Gaucher disease
Johannes M. Aerts et al.
ACTA PAEDIATRICA (2008)
Causes of death in a post-mortem series of ALS patients
Philippe Corcia et al.
AMYOTROPHIC LATERAL SCLEROSIS (2008)
Different content of chitin-like polysaccharides in multiple sclerosis and Alzheimer's disease brains
Stefano Sotgiu et al.
JOURNAL OF NEUROIMMUNOLOGY (2008)
Proteome analysis of cerebrospinal fluid in amyotrophic lateral sclerosis (ALS)
Johannes Brettschneider et al.
NEUROCHEMICAL RESEARCH (2008)
Cerebrospinal fluid-optimized two-dimensional difference gel electrophoresis (2-D DIGE) facilitates the differential diagnosis of Creutzfeldt-Jakob disease
Peter Brechlin et al.
PROTEOMICS (2008)
Cerebrospinal fluid neurofilament light levels in amyotrophic lateral sclerosis:: impact of SOD1 genotype
H. Zetterberg et al.
EUROPEAN JOURNAL OF NEUROLOGY (2007)
Human chitotriosidase polymorphisms G354R and A442V associated with reduced enzyme activity
Pauline Lee et al.
BLOOD CELLS MOLECULES AND DISEASES (2007)
Plasma and CSF serpins in Alzheimer disease and dementia with Lewy bodies
H. M. Nielsen et al.
NEUROLOGY (2007)
Alteration of cystatin C in the cerebrospinal fluid of multiple sclerosis
Ichiro Nakashima et al.
ANNALS OF NEUROLOGY (2007)
Cerebrospinal fluid proteome profile in multiple sclerosis
V. Lehmensiek et al.
MULTIPLE SCLEROSIS (2007)
Proteome analysis of cerebrospinal fluid in Guillain-Barre syndrome (GBS)
V. Lehmensiek et al.
JOURNAL OF NEUROIMMUNOLOGY (2007)
Osteopontin is elevated in Parkinson's disease and its absence leads to reduced neurodegeneration in the MPTP model
Walter Maetzler et al.
NEUROBIOLOGY OF DISEASE (2007)
Amyotrophic lateral sclerosis in south-east England: A population-based study - The south-east England register for amyotrophic lateral sclerosis (SEALS registry)
K. Abhinav et al.
NEUROEPIDEMIOLOGY (2007)
Comparative proteomic profiling of cerebrospinal fluid between living and post mortem ALS and control subjects
Srikanth Ranganathan et al.
AMYOTROPHIC LATERAL SCLEROSIS (2007)
Transferrin localizes in Bunina bodies in amyotrophic lateral sclerosis
Yuji Mizuno et al.
ACTA NEUROPATHOLOGICA (2006)
Chitotriosidase and inflammatory mediator levels in Alzheimer's disease and cerebrovascular dementia
Michelino Di Rosa et al.
EUROPEAN JOURNAL OF NEUROSCIENCE (2006)
Identification of potential CSF biomarkers in ALS
GM Pasinetti et al.
NEUROLOGY (2006)
Axonal damage markers in cerebrospinal fluid are increased in ALS
J Brettschneider et al.
NEUROLOGY (2006)
Identification of CSF biomarkers for frontotemporal dementia using SELDI-TOF
U Rüetschi et al.
EXPERIMENTAL NEUROLOGY (2005)
Proteomic profiling of cerebrospinal fluid identifies biomarkers for amyotrophic lateral sclerosis
S Ranganathan et al.
JOURNAL OF NEUROCHEMISTRY (2005)
Truncated cystatin C in cerebrospiral fluid: Technical artefact or biological process?
O Carrette et al.
PROTEOMICS (2005)
Neurofilament phosphoforms: Surrogate markers for axonal injury, degeneration and loss
A Petzold
JOURNAL OF THE NEUROLOGICAL SCIENCES (2005)
Chitotriosidase in patients with acute ischemic stroke
S Sotgiu et al.
EUROPEAN NEUROLOGY (2005)
Cystatin C as a potential cerebrospinal fluid marker for the diagnosis of Creutzfeldt-Jakob disease
JC Sanchez et al.
PROTEOMICS (2004)
Processing, distribution, and function of VGF, a neuronal and endocrine peptide precursor
A Levi et al.
CELLULAR AND MOLECULAR NEUROBIOLOGY (2004)
A panel of cerebrospinal fluid potential biomarkers for the diagnosis of Alzheimer's disease
O Carrette et al.
PROTEOMICS (2003)
Elevation of cystatin C in susceptible neurons in Alzheimer's disease
A Deng et al.
AMERICAN JOURNAL OF PATHOLOGY (2001)
Dynamics of brain-derived proteins in cerebrospinal fluid
H Reiber
CLINICA CHIMICA ACTA (2001)
El Escorial revisited: Revised criteria for the diagnosis of amyotrophic lateral sclerosis
BR Brooks et al.
AMYOTROPHIC LATERAL SCLEROSIS AND OTHER MOTOR NEURON DISORDERS (2000)
Share Paper
